Applied DNA Sciences (NASDAQ:APDN – Get Free Report) posted its earnings results on Tuesday. The technology company reported ($0.32) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.01, Zacks reports. Applied DNA Sciences had a negative net margin of 214.42% and a negative return on equity of 138.41%.
Applied DNA Sciences Stock Performance
APDN stock opened at $0.23 on Thursday. The firm has a 50 day moving average price of $0.22 and a 200-day moving average price of $0.60. Applied DNA Sciences has a 52-week low of $0.12 and a 52-week high of $14.40. The firm has a market capitalization of $11.93 million, a price-to-earnings ratio of -0.02 and a beta of 0.46.
Analyst Ratings Changes
Separately, StockNews.com upgraded Applied DNA Sciences to a “sell” rating in a research note on Tuesday, September 17th.
About Applied DNA Sciences
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
Further Reading
- Five stocks we like better than Applied DNA Sciences
- How to Invest in the Best Canadian Stocks
- Stock Buybacks Outperform Dividends: Here’s the Key Advantage
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What Investors Need to Know About Upcoming IPOs
- Why Now Is the Ultimate Time to Invest in Oil Stocks
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
